Biosimilars Market Report

Global Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 04, 2020
  • PAGES：174
  • REPORT CODE：GMM536445
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biosimilars is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The research provides insights for the global Biosimilars market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biosimilars industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Biosimilars Market Segmentations:

    By Players:

    • Roche Diagnostics

    • Amgen

    • Hospira

    • Mylan

    • Celltrion

    • Sandoz International

    • Biocon

    • Merck KGaA

    • Teva Pharmaceutical

    By Types:

    • Injection

    • Tablets

    • Others

    By End-User:

    • Ankylosing Spondylitis

    • Tumor

    • Rheumatoid Arthrtis

    • Cardiovascular

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026

      • 1.3.2 Global Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026

      • 1.3.3 Global Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026

      • 1.4.2 Global Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

      • 1.4.3 Global Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026

      • 1.4.4 Global Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Biosimilars Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biosimilars Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilars by Major Types

      • 3.4.1 Biosimilars Market Size and Growth Rate of Injection

      • 3.4.2 Biosimilars Market Size and Growth Rate of Tablets

      • 3.4.3 Biosimilars Market Size and Growth Rate of Others

    4 Segmentation of Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biosimilars in Ankylosing Spondylitis

      • 4.4.2 Market Size and Growth Rate of Biosimilars in Tumor

      • 4.4.3 Market Size and Growth Rate of Biosimilars in Rheumatoid Arthrtis

      • 4.4.4 Market Size and Growth Rate of Biosimilars in Cardiovascular

    5 Market Analysis by Major Regions

    • 5.1 Global Biosimilars Production Analysis by Major Regions

    • 5.2 Global Biosimilars Consumption Analysis by Major Regions

    • 5.3 Global Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Biosimilars Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Commodity of Biosimilars Market in Major Countries

    • 6.1 Top 5 Export Countries in Biosimilars market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biosimilars market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biosimilars market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biosimilars market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biosimilars market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biosimilars market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Biosimilars Landscape Analysis

    • 7.1 North America Biosimilars Landscape Analysis by Major Types

    • 7.2 North America Biosimilars Landscape Analysis by Major End-Users

    • 7.3 North America Biosimilars Landscape Analysis by Major Countries

      • 7.3.1 United States Biosimilars Market Volume and Growth Rate

      • 7.3.2 Canada Biosimilars Market Volume and Growth Rate

      • 7.3.3 Mexico Biosimilars Market Volume and Growth Rate

    8 Europe Biosimilars Landscape Analysis

    • 8.1 Europe Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Biosimilars Landscape Analysis by Major Countries

      • 8.3.1 Germany Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Biosimilars Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Biosimilars Market Volume and Growth Rate

      • 8.3.6 Spain Biosimilars Market Volume and Growth Rate

      • 8.3.7 Belgium Biosimilars Market Volume and Growth Rate

      • 8.3.8 Poland Biosimilars Market Volume and Growth Rate

      • 8.3.9 Russia Biosimilars Market Volume and Growth Rate

      • 8.3.10 Turkey Biosimilars Market Volume and Growth Rate

    9 Asia Pacific Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Biosimilars Landscape Analysis by Major Types

    • 9.2 Asia Pacific Biosimilars Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Biosimilars Landscape Analysis by Major Countries

      • 9.3.1 China Biosimilars Market Volume and Growth Rate

      • 9.3.2 Japan Biosimilars Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Biosimilars Market Volume and Growth Rate

      • 9.3.4 India Biosimilars Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Biosimilars Market Volume and Growth Rate

      • 9.3.6 South Korea Biosimilars Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Biosimilars Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Biosimilars Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Biosimilars Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Biosimilars Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Biosimilars Market Volume and Growth Rate

      • 10.3.2 Brazil Biosimilars Market Volume and Growth Rate

      • 10.3.3 Nigeria Biosimilars Market Volume and Growth Rate

      • 10.3.4 South Africa Biosimilars Market Volume and Growth Rate 

      • 10.3.5 Argentina Biosimilars Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Roche Diagnostics

      • 11.1.1 Roche Diagnostics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Amgen

      • 11.2.1 Amgen Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Hospira

      • 11.3.1 Hospira Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Mylan

      • 11.4.1 Mylan Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Celltrion

      • 11.5.1 Celltrion Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sandoz International

      • 11.6.1 Sandoz International Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Biocon

      • 11.7.1 Biocon Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Merck KGaA

      • 11.8.1 Merck KGaA Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Teva Pharmaceutical

      • 11.9.1 Teva Pharmaceutical Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 80 Figures and 136 Tables)

    • Figure Product Picture

    • Figure Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026

    • Figure Global Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • Figure Global Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026

    • Figure Global Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Injection

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Ankylosing Spondylitis

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Rheumatoid Arthrtis

    • Figure Market Size and Growth Rate of Cardiovascular

    • Table Global Biosimilars Production by Major Regions

    • Table Global Biosimilars Production Share by Major Regions

    • Figure Global Biosimilars Production Share by Major Regions in 2014

    • Figure Global Biosimilars Production Share by Major Regions in 2018

    • Figure Global Biosimilars Production Share by Major Regions in 2026

    • Table Global Biosimilars Consumption by Major Regions

    • Table Global Biosimilars Consumption Share by Major Regions

    • Figure Global Biosimilars Consumption Share by Major Regions in 2014

    • Figure Global Biosimilars Consumption Share by Major Regions in 2018

    • Figure Global Biosimilars Consumption Share by Major Regions in 2026

    • Table North America Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Biosimilars Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biosimilars market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biosimilars market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Biosimilars Consumption by Types from 2014 to 2026

    • Table North America Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure North America Biosimilars Consumption Share by Types in 2014

    • Figure North America Biosimilars Consumption Share by Types in 2018

    • Figure North America Biosimilars Consumption Share by Types in 2026

    • Table North America Biosimilars Consumption by End-Users from 2014 to 2026

    • Table North America Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure North America Biosimilars Consumption Share by End-Users in 2014

    • Figure North America Biosimilars Consumption Share by End-Users in 2018

    • Figure North America Biosimilars Consumption Share by End-Users in 2026

    • Table North America Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Europe Biosimilars Consumption Share by Types in 2014

    • Figure Europe Biosimilars Consumption Share by Types in 2018

    • Figure Europe Biosimilars Consumption Share by Types in 2026

    • Table Europe Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Biosimilars Consumption Share by End-Users in 2014

    • Figure Europe Biosimilars Consumption Share by End-Users in 2018

    • Figure Europe Biosimilars Consumption Share by End-Users in 2026

    • Table Europe Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Biosimilars Consumption Share by Major Countries in 2014

    • Figure Europe Biosimilars Consumption Share by Major Countries in 2018

    • Figure Europe Biosimilars Consumption Share by Major Countries in 2026

    • Figure Germany Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption by Types from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Biosimilars Consumption Share by Types in 2014

    • Figure Asia Pacific Biosimilars Consumption Share by Types in 2018

    • Figure Asia Pacific Biosimilars Consumption Share by Types in 2026

    • Table Asia Pacific Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Biosimilars Consumption Share by End-Users in 2014

    • Figure Asia Pacific Biosimilars Consumption Share by End-Users in 2018

    • Figure Asia Pacific Biosimilars Consumption Share by End-Users in 2026

    • Table Asia Pacific Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Biosimilars Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Biosimilars Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Biosimilars Consumption Share by Major Countries in 2026

    • Figure China Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandBiosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Biosimilars Consumption Share by Major Countries in 2026

    • Figure GCC Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Sandoz International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International

    • Figure Sales and Growth Rate Analysis of Sandoz International

    • Figure Revenue and Market Share Analysis of Sandoz International

    • Table Product and Service Introduction of Sandoz International

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US